EVEROLIMUS | N022334 | NOVARTIS PHARMACEUTICALS CORP
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2018-00507 | 8410131 | IPR | Hikma Pharmaceuticals PLC | Terminated-Settled | 2018-01-17 | — |
| IPR2017-01592 | 8410131 | IPR | Breckenridge Pharmaceutial, Inc. | Terminated-Settled | 2017-06-12 | — |
| IPR2017-01078 | 9006224 | IPR | West-Ward Pharmaceuticals International Limited | Terminated-Settled | 2017-03-13 | — |
| IPR2017-01063 | 9006224 | IPR | Argentum Pharmaceuticals LLC et al. | Final Written Decision | 2017-03-10 | — |
| IPR2016-01479 | 9006224 | IPR | Par Pharmaceutical, Inc. et al. | Final Written Decision | 2016-07-22 | — |
| IPR2016-01461 | 9006224 | IPR | Roxane Laboratories, Inc. et al. | Institution Denied | 2016-07-19 | — |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2019-06-05 | Terminated 2020-01-10 | — | |
| D. Del. | 2017-04-13 | Terminated 2019-03-07 | — | |
| D. Del. | 2017-04-07 | Terminated 2018-02-26 | — | |
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc. 3 patentseverolimus | D. Del. | 2015-01-23 | Terminated 2019-05-01 | — |
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc. 3 patentseverolimus | D. Del. | 2014-12-18 | Terminated 2019-05-01 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
AngioScore, Inc. - Citizen Petition FDA-2008-P-0473 · 4 docket documents AngioScore, Inc. filed this citizen petition on August 19, 2008, requesting that the FDA deny Abbott Cardiovascular Systems Inc.'s application for patent term extension of U.S. Patent No. 5,451,233 based on the FDA's July 2, 2008 approval of the XIENCE V Everolimus Eluting Coronary Stent System unde | Other | 2008-08-22 | Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.